Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care
- PMID: 32684340
- PMCID: PMC7348590
- DOI: 10.1016/j.jmii.2020.07.003
Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care
Abstract
Clinical applicability of rapid diagnostic test kit for SARS-CoV-2 antibodies was evaluated. The kit detected antibodies from day 9-56 of illness. IgG bands were observed up to 1: 1000 dilutions. The kit could detect 90.5% of IgG and 61.9% of IgM antibodies of mild febrile patients without pneumonia.
Keywords: Antibody; Point-of-care test; Rapid diagnostic test; SARS-CoV-2; Titration.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflict of interest.
Figures
References
-
- Korean Society of Infectious Diseases KSoPID, Korean Society of Epidemiology , Korean Society for Antimicrobial therapy , Korean Society for Healthcare-Associated Infection Control and Prevention and Korea Centers for Disease Control and Prevention Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Kor Med Sci. 2020;35 - PMC - PubMed
-
- Xiang J., Yan M., Li H., Liu T., Lin C., Huang S. Evaluation of enzyme-linked immunoassay and colloidal gold- immunochromatographic assay kit for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19) medRxiv. 2020;2020 02.27.20028787.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
